CADx gains approvable letter:
This article was originally published in Clinica
CADx Medical Systems looks set to become the second firm to gain US approval to sell its computer-aided detection (CAD) system for use with mammography, after the company received an approvable letter from the FDA for its Second Look CAD product. Marketing clearance for the device is subject to final labelling discussions with the FDA. A competing firm, R2 Technology, gained FDA approval for its mammography CAD product, ImageChecker, in 1998.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.